Rizi Ai
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Cancer-related molecular mechanisms research
Papers in
-
- Hepatitis C virus research 3
-
- Autoimmune and Inflammatory Disorders Research 3
- Co-authors
- Gary S. FiresteinDavid L. BoyleShicai FanDeepa HammakerWei WangMengchi WangJohn W. WhitakerAndré Wildberg
- Journals
- ACR Open Rheumatology (3 papers)Nature Communications (2 papers)Bioinformatics (2 papers)Arthritis & Rheumatology (2 papers)G3 Genes Genomes Genetics (1 paper)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Rizi Ai
17 papers receiving 570 citations
Peers
Comparison fields: 5 of 67
- Rheumatology 191
- Cancer Research 126
- Hematology 85
- Immunology 114
- Molecular Biology 332
Countries citing papers authored by Rizi Ai
This map shows the geographic impact of Rizi Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizi Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizi Ai more than expected).
Fields of papers citing papers by Rizi Ai
This network shows the impact of papers produced by Rizi Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizi Ai. The network helps show where Rizi Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Rizi Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 21 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 7 | |
| 7 | 2019 | 37 | |
| 8 | 2019 | 27 | |
| 9 | 2019 | 23 | |
| 10 | 2018 | 132 | |
| 11 | 2018 | 4 | |
| 12 | 2016 | 42 | |
| 13 | 2016 | 97 | |
| 14 | 2016 | 28 | |
| 15 | 2016 | 22 | |
| 16 | 2015 | 59 | |
| 17 | 2015 | 70 |
About Rizi Ai
Rizi Ai is a scholar working on Hepatology, Hematology, Rheumatology, Virology and Immunology, having authored 17 papers that have together received 587 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (4 papers), Epigenetics and DNA Methylation (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Hepatitis C virus research (3 papers), interferon and immune responses (2 papers), Nonmelanoma Skin Cancer Studies (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Rheumatology (191 citations), Cancer Research (126 citations), Hematology (85 citations), Immunology (114 citations) and Molecular Biology (332 citations). Rizi Ai has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Gary S. Firestein, David L. Boyle, Shicai Fan, Deepa Hammaker, Wei Wang, Mengchi Wang, John W. Whitaker, Wei Wang, André Wildberg and Bo Ding. Their work appears in journals such as ACR Open Rheumatology, Nature Communications, Bioinformatics, Arthritis & Rheumatology and G3 Genes Genomes Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.